Editorial
Published on 15 Aug 2022
Editorial: Leveraging pharmacovigilance data mining with “the patient” in mind
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2022.980645
- 2,363 views
24 articles related to "Pharmacovigilance Data"
Articles
Original Research
Published on 15 Apr 2022
Anti-cancer Drugs Associated Atrial Fibrillation—An Analysis of Real-World Pharmacovigilance Data
in Cardio-Oncology
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2022.739044
- 9,904 views
- 30 citations
Mini Review
Published on 13 Nov 2024
Integrating electronic health records with other data sources for postmarket drug safety signal identification: a review
in Advanced Methods in Pharmacovigilance and Pharmacoepidemiology
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2024.1428831
- 3,785 views
- 6 citations
Review
Published on 11 Apr 2016
Patient Participation and the Use of Ehealth Tools for Pharmacoviligance
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2016.00090
- 8,443 views
- 24 citations
Perspective
Published on 16 Aug 2021
Increase of Adverse Events After Intravenous Injection of Gentamicin in Horses Between 2015 and 2017—From Marketing Authorization Holder's Point of View
in Veterinary Pharmacology and Toxicology
Frontiers in Veterinary Science
doi 10.3389/fvets.2021.710571
- 12,913 views
- 4 citations
Review
Published on 02 Jul 2019
Lichen Planus Pemphigoides: From Lichenoid Inflammation to Autoantibody-Mediated Blistering
in Autoimmune and Autoinflammatory Disorders
Frontiers in Immunology
doi 10.3389/fimmu.2019.01389
- 45,387 views
- 116 citations
Original Research
Published on 30 Apr 2024
Adverse events associated with immune checkpoint inhibitors in non-small cell lung cancer: a safety analysis of clinical trials and FDA pharmacovigilance system
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1396752
- 10,958 views
- 9 citations
Original Research
Published on 18 Mar 2024
Examining the safety of mirabegron: an analysis of real-world pharmacovigilance data from the US FDA adverse event reporting system (FAERS) database
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1376535
- 10,310 views
- 11 citations
Original Research
Published on 13 Dec 2022
Can glucagon-like peptide-1 receptor agonists cause acute kidney injury? An analytical study based on post-marketing approval pharmacovigilance data
in Clinical Diabetes
Frontiers in Endocrinology
doi 10.3389/fendo.2022.1032199
- 15,812 views
- 31 citations
Review
Published on 09 Jul 2014
Herbal medicines in Brazil: pharmacokinetic profile and potential herb-drug interactions
in Ethnopharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2014.00162
- 26,921 views
- 55 citations
Original Research
Published on 24 Nov 2021
Pan-Cancer Analysis Reveals Alternative Splicing Characteristics Associated With Immune-Related Adverse Events Elicited by Checkpoint Immunotherapy
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2021.797852
- 6,945 views
- 9 citations
Original Research
Published on 23 Feb 2024
Identifying in-market application of Pelargonium root extract EPs 7630 for the treatment of COVID-19: analysis of pharmacovigilance data
in Ethnopharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1335309
- 3,932 views
- 6 citations
Original Research
Accepted on 02 Feb 2026
Patterns of Neurologic and Psychiatric Toxicity Burden of Different Endocrine Therapeutics for Breast Cancer: A Global Pharmacovigilance Study Based on FAERS and VigiAccess
in Pharmacoepidemiology
Frontiers in Pharmacology
- 158 views
Original Research
Published on 29 Oct 2024
Region-independent active CNS net uptake of marketed H+/OC antiporter system substrates
in Non-Neuronal Cells
Frontiers in Cellular Neuroscience
doi 10.3389/fncel.2024.1493644
- 3,119 views
- 1 citation
Original Research
Published on 16 Feb 2026
Characterization of skin adverse events associated with cetuximab: real-world insights from the two global pharmacovigilance databases of FAERS and VigiAccess
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2026.1768984
- 246 views
Original Research
Published on 20 Jan 2026
Unveiling the hidden cardiovascular risk of sipuleucel-T: a pharmacovigilance analysis using the FDA Adverse Event Reporting System, 2010–2025
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1716090
- 1,143 views